A repeated measures model for analysis of continuous outcomes in sequential parallel comparison design studies
暂无分享,去创建一个
Michael Pencina | Allison Meisner | Maurizio Fava | Gheorghe Doros | Denis Rybin | M. Pencina | M. Fava | D. Rybin | G. Doros | A. Meisner
[1] R. Sysko,et al. Placebo response in studies of major depression: variable, substantial, and growing. , 2002, JAMA.
[2] David A. Schoenfeld,et al. The Problem of the Placebo Response in Clinical Trials for Psychiatric Disorders: Culprits, Possible Remedies, and a Novel Study Design Approach , 2003, Psychotherapy and Psychosomatics.
[3] Anastasia Ivanova,et al. Optimality, sample size, and power calculations for the sequential parallel comparison design , 2011, Statistics in medicine.
[4] Xiaohong Huang,et al. Estimation of treatment effect for the sequential parallel design , 2011, Statistics in medicine.
[5] M. Pencina,et al. A Double-Blind, Placebo-Controlled Study of Aripiprazole Adjunctive to Antidepressant Therapy among Depressed Outpatients with Inadequate Response to Prior Antidepressant Therapy (ADAPT-A Study) , 2012, Psychotherapy and Psychosomatics.
[6] Xiaohong Huang,et al. An examination of the efficiency of the sequential parallel design in psychiatric clinical trials , 2007, Clinical trials.
[7] Yang Yang,et al. Evaluation of performance of some enrichment designs dealing with high placebo response in psychiatric clinical trials. , 2011, Contemporary clinical trials.
[8] Joseph W Hogan,et al. Handling drop‐out in longitudinal studies , 2004, Statistics in medicine.
[9] R. Little,et al. The prevention and treatment of missing data in clinical trials. , 2012, The New England journal of medicine.
[10] Roy N. Tamura,et al. Comparison of Test Statistics for the Sequential Parallel Design , 2010 .
[11] M. Trivedi,et al. Does a Placebo Run-In or a Placebo Treatment Cell Affect the Efficacy of Antidepressant Medications? , 1994, Neuropsychopharmacology.